Peptide record

TPDB92528

iRGD Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92528
iRGD
Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 MLCPP 2.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 9-aa modified multi-activity (Anticancer, Blood-Brain Barrier, Cell-penetrating Peptides, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
C-terminal: Cysteine N-terminal: Cysteine
Sequence
CRGDKGPDC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
Cysteine Activity
CendR Activity
Cysteine Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell
Homing
Breast cancer
Neuropilin-1 (NRP-1)

Source & Reference

TumorHoPe2.0
TumorHoPe2
Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
2017
Xiangsheng Liu et al. J Clin Invest. 2017 May 1 127(5):2007-2018.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
4T1 breast cancer cells
Phage Display Library
Mesoporous silica nanoparticles (MSNPs), irinotecan, Doxorubicin (DOX)
Additional Detail Fields 2 fields
Mesoporous silica nanoparticles (MSNPs), irinotecan, Doxorubicin (DOX)
4T1 breast cancer cells